Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Clinical trial NCT04518501 · RECRUITING
Trial details
- NCT number
- NCT04518501
- Sponsor
- Xing Xie
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2024-12-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.